BioNTech's quarterly results led market analysts to update their financial estimates.
2 reports, 2 independent
Updated Aug 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioNTech's quarterly results led market analysts to update their financial estimates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BioNTech
Biotechnology company from Germany
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.BioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates It's been a good week for BioNTech SE (NASDAQ:BNTX) shareholders, because the company has
- TipRanksBioNTech price target raised to $185 from $181 at Clear Street Clear Street raised the firm’s price target on BioNTech (BNTX) to $185 from $181 and keeps a Buy rating on the shares after updating the